awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36859619-6AEC6071-0BC5-4645-9E45-5429056BF771
Q36859619-6AEC6071-0BC5-4645-9E45-5429056BF771
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36859619-6AEC6071-0BC5-4645-9E45-5429056BF771
Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme
P2860
Q36859619-6AEC6071-0BC5-4645-9E45-5429056BF771
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36859619-6AEC6071-0BC5-4645-9E45-5429056BF771
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6fecc1f0a2fc5c2cfbfaec92a6025654f340826f
P2860
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.